Bio-Path Holdings creates Series B preferred stock class with 5 million authorized shares
BPTH•Conversion and voting terms
Each Series B Preferred share converts into 1,000 common shares, voting on an as-converted basis. The Series B Preferred carries no dividends and no liquidation amount above $0.01 par value.
Series B Preferred stock class created
Bio-Path Holdings created a new class of Series B Preferred stock on July 14, 2026, authorizing 5,000,000 shares.
